# A Study Evaluating the Efficacy and Impact on Health-related Quality of Life of Levocetirizine in Adults With Seasonal Allergic Rhinitis

> **NCT00653224** · PHASE4 · COMPLETED · sponsor: **UCB Pharma** · enrollment: 580 (actual)

## Conditions studied

- Seasonal Allergic Rhinitis

## Interventions

- **DRUG:** levocetirizine dihydrochloride
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00653224
- **Lead sponsor:** UCB Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-04
- **Primary completion:** 2008-07
- **Final completion:** 2008-07
- **Target enrollment:** 580 (ACTUAL)
- **Last updated:** 2011-08-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00653224

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00653224, "A Study Evaluating the Efficacy and Impact on Health-related Quality of Life of Levocetirizine in Adults With Seasonal Allergic Rhinitis". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT00653224. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*